Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19975111 | 0.87 | ALDH1A1 (0.38) | HRH3HRH4MEN1KMT2A | |
| SCHEMBL19975343 | 0.81 | HRH3 (0.40) | HRH3HRH4 | |
| SCHEMBL4605470 | 0.79 | MEN1 (0.45) | HRH3HRH4MEN1KMT2A | |
| SCHEMBL7158594 | 0.79 | — | — | |
| SCHEMBL3961101 | 0.76 | — | — | |
| SCHEMBL1331771 | 0.76 | MEN1 (0.38) | HRH3MEN1KMT2A | |
| SCHEMBL7449177 | 0.75 | ALDH1A1 (0.40) | HRH3HRH4KMT2A | |
| SCHEMBL19974655 | 0.74 | ELANE (0.41) | ELANEHRH3MEN1KMT2A | |
| SCHEMBL13134162 | 0.73 | KMT2A (0.36) | ELANEHRH3MEN1KMT2A | |
| SCHEMBL19974645 | 0.71 | MEN1 (0.38) | HRH3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512840-A1 | NOVEL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS | Tseng, Yufeng, Jane (US) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018053161-A1 | NOVEL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS | NATIONAL TAIWAN UNIVERSITY (TW) | 2018-03-22 | — | — | WO | disclosed |